
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
The number of people infected with HIV or living with AIDS is increasing at unprecedented rates as various scientists, organizations, and institutions search for innovative solutions to combating and preventing the disease. At the request of the Bill & Melinda Gates Foundation, Methodological Challenges in Biomedical HIV Prevention Trials addresses methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials. This book recommends a number of ways to improve the design, monitoring, and analysis of late-stage clinical trials that evaluate nonvaccine biomedical interventions. The objectives include identifying a beneficial method of intervention, enhancing quantification of the impact, properly assessing the effects of using such an intervention, and reducing biases that can lead to false positive trial results.According to Methodological Challenges in Biomedical HIV Prevention Trials, the need to identify a range of effective, practical, and affordable preventive strategies is critical. Although a large number of promising new HIV prevention strategies and products are currently being tested in late-stage clinical trials, these trials face a myriad of methodological challenges that slow the pace of research and limit the ability to identify and fully evaluate effective biomedical interventions.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- COVER PAGE
- THE NATIONAL ACADEMIES
- COMMITTEE ON THE METHODOLOGICAL CHALLENGES IN HIV PREVENTION TRIALS
- Reviewers
- Contents
- Summary
- Introduction
- 1 The Status and Challenges of Biomedical HIV Prevention Trials
- 2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group
- 3 Design Considerations: Risk-Reduction Counseling
- 4 Design Considerations: Pregnancy
- 5 Design Considerations: Adherence
- 6 Design Considerations: Recruitment and Retention
- 7 Site Preparedness
- 8 Estimating HIV Incidence
- 9 Interim Monitoring and Analysis of Results
- 10 Alternative Designs
- Appendix A Public Committee Meeting Agendas
- Appendix B Acronyms
- Appendix C Supporting Materials for Chapter 2
- Appendix D Methods for Analyzing Adherence
- Appendix E Committee Biographies